Compare GTLS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTLS | CRL |
|---|---|---|
| Founded | 1859 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.3B |
| IPO Year | N/A | 1999 |
| Metric | GTLS | CRL |
|---|---|---|
| Price | $207.49 | $179.54 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $203.22 | $197.58 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $8.33 | $2.51 |
| Revenue Next Year | $11.45 | $4.66 |
| P/E Ratio | $240.25 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $104.60 | $91.86 |
| 52 Week High | $208.24 | $228.88 |
| Indicator | GTLS | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 57.69 | 47.38 |
| Support Level | $206.71 | $145.97 |
| Resistance Level | $207.77 | $182.81 |
| Average True Range (ATR) | 0.42 | 9.64 |
| MACD | -0.01 | 1.38 |
| Stochastic Oscillator | 80.95 | 77.01 |
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.